BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15643000)

  • 1. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.
    Tsang RS; Zollinger WD
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):152-6. PubMed ID: 15643000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
    Chanteau S; Dartevelle S; Mahamane AE; Djibo S; Boisier P; Nato F
    PLoS Med; 2006 Sep; 3(9):e337. PubMed ID: 16953658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
    Lal G; Balmer P; Joseph H; Dawson M; Borrow R
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
    Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
    Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease.
    Bennett DE; Cafferkey MT
    J Clin Microbiol; 2006 Mar; 44(3):1127-31. PubMed ID: 16517911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
    de Voer RM; Schepp RM; Versteegh FG; van der Klis FR; Berbers GA
    Clin Vaccine Immunol; 2009 Mar; 16(3):433-6. PubMed ID: 19129470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
    Deeks ED
    Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of Neisseria meningitidis serogroups Y and W135 by siaD nucleotide sequence analysis.
    Lewis C; Clarke SC
    J Clin Microbiol; 2003 Jun; 41(6):2697-9. PubMed ID: 12791908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.
    Trotter CL; Findlow H; Borrow R
    Clin Vaccine Immunol; 2012 Feb; 19(2):219-22. PubMed ID: 22190393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antiserum agar method for the serogroup differentiation of Neisseria meningitidis Y and W135.
    Ashton FE; Ryan A; Diena BB
    Can J Microbiol; 1980 May; 26(5):630-2. PubMed ID: 6772290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.
    Chiou CS; Liao JC; Liao TL; Li CC; Chou CY; Chang HL; Yao SM; Lee YS
    BMC Infect Dis; 2006 Feb; 6():25. PubMed ID: 16478548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.
    Pollard AJ; Ochnio J; Ho M; Callaghan M; Bigham M; Dobsong S
    Emerg Infect Dis; 2004 Oct; 10(10):1812-5. PubMed ID: 15504268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
    Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
    J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.